Premium Information is available for this item - Upgrade for $1 a day

6505-00-057-2124

Usp Methysergide Maleate Tablets

6505000572124 000572124 SANSERT

6505-00-057-2124 METHYSERGIDE MALEATE TABLETS,USP 6505000572124 000572124

Managed by United States
NSN Created on 1 Jan 1961
Data Last Changed
November 2023
NATO Update Count
7
NATO Data Quality
6505-00-057-2124 METHYSERGIDE MALEATE TABLETS,USP 6505000572124 000572124 1/1
NSN 6505-00-057-2124 (Generic Image) 1/1

6505-00-057-2124 Stock and Availability Marketplace 6505-00-057-2124

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-00-057-2124 RQST NE eBay
eBay Updated Every Day
6505-00-057-2124 RQST eBay
Amazon Updated Every Day
6505-00-057-2124 RQST NE Amazon

6505-00-057-2124 Related Documents Related Documents 6505-00-057-2124 5+ Documents (More...)

your web browser . 6505-21-912-7348Methysergide Maleate Tablets6505219127348 219127348 DIN 00027499 SANSERT
Upgrade your Account Upgrade 6505-00-057-2124Usp Methysergide Maleate Tablets6505000572124 000572124
SANSERT (Active) Primary Buy RNCC 3 RNVC 2 DAC 6 SANSERT 04520 - Novartis Pharmaceuticals Corp. https
Upgrade your Account Upgrade 6505-00-330-7191Usp Methysergide Maleate Tablets6505003307191 003307191 SANSERT
Usp Methysergide Maleate Tablets 000572124 Upgrade your Account Upgrade 6505-00-057-2124Usp Methysergide
Maleate Tablets6505000572124 000572124 SANSERT Quantity [CRLK]50.000 Tablets NATO Stock Numbers Related
(CAGE Code 04520) 6505-00-057-2124 Usp Methysergide Maleate Tablets SANSERTRNCC: 3 | RNVC: 1 | DAC: 4
21-899-8221 Usp Bromocriptine Mesylate Tablets PARLODELRNCC: 3 | RNVC: 1 | DAC: 4 6 Aug 1985 6505-00-057-2124
-7191 Usp Methysergide Maleate Tablets NDC00078-0058-05RNCC: 3 | RNVC: 2 | DAC: 6 9 Dec 1973 6505-00-057-2124

6505-00-057-2124 Demil Restrictions 6505-00-057-2124

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: U | EDC: | ADPEC:

6505-00-057-2124 is a Usp Methysergide Maleate Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.

6505-00-057-2124 End Users End Users 6505-00-057-2124

NASA (G57V)
Effective Date:
1 Apr 1991

6505-00-057-2124 Manufacturers Approved Sources 6505-00-057-2124

6505-00-057-2124 Technical Data Datasheet 6505-00-057-2124

Characteristic
Specifications
Active Medicament Medicinal Strength [AKJA]
2.000 Milligrams Methysergid(E) Maleate Active Ingredient
Administration [CSGS]
Oral
Primary Container Type [CQCT]
Bottle
Primary Container Content Quantity [CRLK]
50.000 Tablets

6505-00-057-2124 Related Items NATO Stock Numbers Related to 6505-00-057-2124

6505-00-057-2124 Freight Data Freight Information 6505-00-057-2124

6505-00-057-2124 has freight characteristics.. 6505-00-057-2124 has a variance between NMFC and UFC when transported by rail and the description should be consulted.